Data For: Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction

Mendeley Data2020-05-13 更新2026-04-09 收录

心力衰竭药物疗效评估

运动耐量临床试验

数据链接：

https://data.mendeley.com/datasets/5dx395tg48 数据链接链接失效反馈

官方服务：

资源简介：

Raw data for the article: Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction.

创建时间：

2020-05-13

RAW DATA of the paper IMPROVEMENT OF FUNCTIONAL CAPACITY IN SACUBITRIL-VALSARTAN TREATED PATIENTS ASSESSED BY CARDIOPULMONARY EXERCISE TEST

心力衰竭药物疗效评估

心肺运动测试分析

Neprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, i.e. ARNI) is recommended in heart failure guidelines for patients in NYHA class II-III with reduced left ventricular ejection fra

NIAID Data Ecosystem40

心力衰竭药物疗效评估

超声心动图分析

This record contains raw data related to the article "Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan". Abstract: In terms of sacu

Zenodo2021-10-06 更新00

Raw data of paper entitled: "Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF)"

心力衰竭药物疗效评估

睡眠呼吸暂停

The mechanisms underlying the effects of dapagliflozin in heart failure with reduced ejection fraction (HFrEF) are not yet fully understood. This study aims to evaluate the effect of the drug on cardi

Zenodo2026-05-25 更新00

Dataset from A Phase III Randomised, Double-blind Trial to Evaluate the Effect of 12 Weeks Treatment of Once Daily EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Reduced Ejection Fraction (HFrEF) (EMPERIAL-reduced)

心力衰竭药物疗效评估

射血分数降低型心衰

The primary objective of the study is to evaluate the effect of empagliflozin 10 mg versus placebo on exercise ability using the 6 minute walk test in patients with chronic HF with reduced ejection

NIAID Data Ecosystem20

Dataset from A Multi-center, Prospective, Randomized, Double-blind Study to Assess the Impact of Sacubitril/Valsartan vs. Enalapril on Daily Physical Activity Using a Wrist Worn Actigraphy Device in Adult Chronic Heart Failure Patients

心力衰竭药物疗效评估

可穿戴设备临床监测

The purpose of this randomized, actively controlled, double-blind study with prospective data collection was to assess differences between sacubitril/valsartan versus enalapril in increasing exercise

NIAID Data Ecosystem00

Data For: Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction

资源简介：

相关数据集